Douglas A. Roeder, Director, 10% Owner at TriVascular Technologies, Inc. (TRIV), bought 1,803,500 shares at $12.00 ($10.0M) on 2014-04-22, disclosed to the SEC on 2014-04-24.
Open-market purchase of $10.0M TRIV by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 970,167 | $0 | 0.0% |
| 2 | $12.00 | 833,333 | $10.0M | 100.0% |
| Total | $5.54 avg | 1,803,500 | $10.0M | 100% |
| Filing → |
| SENS | BUY | 2026-03-16 | $100K | — | Filing → |
| SENS | BUY | 2025-11-10 | $87K | — | Filing → |
| SENS | BUY | 2024-12-20 | $38K | — | Filing → |